Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.21 is in line with its 5-year average of 2.39, near the low end of its 5-year range (0.05–7.87).
As of the fiscal period ended Tuesday, June 30, 2026. 149.13% above its 12-month average of 0.89.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.21.
CURRENT RATIO
2.21
CURRENT RATIO AVG TTM
0.89
CURRENT RATIO AVG 3Y
0.39
CURRENT RATIO AVG 5Y
2.39
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+149.13%
CURRENT VS 3Y AVG
+462.08%
CURRENT VS 5Y AVG
-7.48%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-40.96%
vs the sector median at left
Market Cap
$2.37M
Current Ratio
2.64
TTM Avg
2.37
3Y Avg
1.52
5Y Avg
1.27
Market Cap
$2.38M
Current Ratio
0.11
TTM Avg
0.75
3Y Avg
3.92
5Y Avg
2.68
Market Cap
$2.32M
Current Ratio
12.91
TTM Avg
22.35
3Y Avg
19.50
5Y Avg
14.70
Market Cap
$2.54M
Current Ratio
1.44
TTM Avg
1.74
3Y Avg
3.93
5Y Avg
2.64
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Onconetix, Inc. (ONCO) | $2.37M | 2.21 | 0.89 | 0.39 | 2.39 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 2.64 | 2.37 | 1.52 | 1.27 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.11 | 0.75 | 3.92 | 2.68 |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.94 | 1.19 | 3.93 | 6.93 |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 12.91 | 22.35 | 19.50 | 14.70 |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 0.69 | 1.06 | 1.22 | 1.34 |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | 1.44 | 1.74 | 3.93 | 2.64 |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | 1.97 | 2.58 | 3.16 | 4.38 |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 0.21 | 0.87 | 0.72 | 1.52 |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | 1.54 | 2.65 | 3.41 | 4.73 |
Current Ratio
2.21
Quick Ratio
2.14
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.21 |
| 2026-03-31 | 1.41 |
| 2025-12-31 | 0.66 |
| 2025-09-30 | 0.08 |
| 2025-06-30 | 0.07 |
| 2025-03-31 | 0.17 |
| 2024-12-31 | 0.05 |
| 2024-09-30 | 0.06 |
| 2024-06-30 | 0.10 |
| 2024-03-31 | 0.29 |
| 2023-12-31 | 0.34 |
| 2023-09-30 | 0.54 |
| 2023-06-30 | 0.94 |
| 2023-03-31 | 7.87 |
| 2022-12-31 | 6.69 |
| 2022-09-30 | 6.74 |
| 2022-06-30 | 7.61 |
| 2022-03-31 | 6.73 |
| 2021-12-31 | 1.41 |
| 2021-09-30 | 3.86 |
| 2021-03-31 | 0.00 |
